Head of the Atomic Energy Organization of Iran (AEOI) Ali Akbar Salehi Thursday unveiled two new domestically-developed radio medicines.

Salehi made the inauguration during a tour of an exhibition of technological and research achievements of the Research Center for Nuclear Science and Technology.

The new radio medicines, LU177-Rituximab and LU177-Trastuzumab, have been designed for cancer treatment.

Both radio medicines have successfully undergone clinical tests at the nuclear medicine unit of Bushehr University of Medical Sciences.